March 31, 2026
Lily Rajaee’s Abstract Melanoma is a serious form of skin cancer that causes nearly 80% of skin cancer–related deaths. While new treatment options with im...
Bryan Weselman’s Abstract While new treatment options for metastatic melanoma that activate the immune system to target cancer have helped some patients live longer,...
Joy Xie’s Abstract Skin cancer is the most common cancer in the United States, and nearly one in five Americans will develop it during their lifetime. While most pr...
Jaclyn Roland-McGowan’s Abstract This research project explores how different versions of a patient decision aid can help people make informed choices about their ski...
Jonathan Hwang’s Abstract Uveal melanoma (UM) is a rare but serious eye cancer. It has a high chance of metastatic spread, especially in advanced stages, which signif...
Julyssa Renteria’s Abstract Melanoma, a serious type of skin cancer, affects people differently based on their racial background. Non-Caucasian groups, such as Black,...
Haarisudhan Sureshkumar’s Abstract Uveal melanoma (UM) is the most common intraocular malignancy in adults and is known to have a poor prognosis. Although the genetic...
Marin Melloy’s Abstract Melanoma causes the most deaths among skin cancers, and cases have been rising in recent years. While we know some of the main genetic factors...
Kathleen N Klinzing’s Abstract The immune system can recognize and kill cancer cells. One cell type that excels at this is the cytotoxic T cell, or CD8+ T cell. CD8+ ...
Sidharth Jain’s Abstract Melanocytes are a type of pigment-producing cell found in skin, hair, and eyes, but can form melanoma, a highly aggressive and deadly type of...
Hannah Wu’s Abstract This research explores the intricate relationship between proteins in the tumor environment, known as the extracellular matrix (ECM), and the beh...
Zachary Walsh’s Abstract T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly pro...
Apr 06, 2026 ET
Apr 17, 2026 ET - Apr 19, 2026
Apr 19, 2026 PT
May 02, 2026 PT
May 09, 2026 ET
